Durable Effect of Radioactive Iodine in a Patient with Metastatic Follicular Thyroid Carcinoma
Objective. Thyroid cancer is the most common endocrine malignancy and fastest increasing of all cancers in both men and women in the United States. Traditionally, differentiated thyroid cancer (DTC) carries a good prognosis when diagnosed early, but increasingly patients are presenting with late-sta...
Saved in:
Main Authors: | Aubrey A. Carhill, Rena Vassilopoulou-Sellin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Case Reports in Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2012/231912 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thyroid-Associated Ophthalmopathy after Radioactive Iodine Therapy for Metastatic Follicular Thyroid Carcinoma
by: Daisuke Murayama, et al.
Published: (2021-01-01) -
Radioactive Iodine Administration Is Associated with Persistent Related Symptoms in Patients with Differentiated Thyroid Cancer
by: Pablo Florenzano, et al.
Published: (2016-01-01) -
Follicular Thyroid Carcinoma Metastatic to the Kidney: Report of a Case with Cytohistologic Correlation
by: Vikas Nath, et al.
Published: (2015-01-01) -
Early Sialadenitis After Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Prevalence and Predictors
by: Ruba Riachy, et al.
Published: (2020-01-01) -
Analyzing Serum Level Changes in Dehydroepiandrosterone Sulfate, Dihydrotestosterone, Progesterone, and Prolactin after Radioactive Iodine Treatment for Papillary Thyroid Carcinoma
by: Mehrosadat Alavi, et al.
Published: (2024-07-01)